Analyst Reco. Amgen Inc.

Equities

AMGN

US0311621009

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-07 pm EDT			5-day change	1st Jan Change
305 ^USD	-0.22%		-0.27%	+5.90%

Jun. 07	AbbVie's tight grip on Humira market raises concerns about biosimilars	RE
Jun. 06	Transcript : Amgen Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-06-2024 09:00 AM

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

HSBC Adjusts Price Target on Amgen to $356 From $322	May. 20	MT
Redburn Adjusts Price Target on Amgen to $170 From $180, Keeps Sell Rating	May. 13	MT
ANALYST RECOMMENDATIONS : UBER, Luluemon, Airbnb, Progressive...	May. 09
Redburn Atlantic Adjusts Price Target on Amgen to $180 From $170	May. 09	MT
Mizuho Securities Raises Amgen's Price Target to $235 From $223	May. 08	MT
North American Morning Briefing : Stock Futures -2-	May. 06	DJ
UBS Adjusts Price Target on Amgen to $307 From $284, Maintains Neutral Rating	May. 03	MT
Deutsche Bank Adjusts Price Target on Amgen to $310 From $285, Hold Rating Maintained	May. 03	MT
William Blair Upgrades Amgen to Outperform From Market Perform	May. 03	MT
Leerink Adjusts Price Target on Amgen to $352 From $324, Keeps Market Perform Rating	May. 03	MT
Novo Nordisk drops 5% after rival Amgen teases weight-loss drug data	May. 03	RE
Barclays Upgrades Amgen to Equalweight From Underweight, Adjusts Price Target to $300 From $230	May. 03	MT
Morgan Stanley Adjusts Price Target on Amgen to $310 From $271, Keeps Equalweight Rating	May. 03	MT
RBC Adjusts Price Target on Amgen to $328 From $332, Keeps Outperform Rating	May. 03	MT
BMO Capital Adjusts Price Target on Amgen to $355 From $336, Keeps Outperform Rating	May. 03	MT
Goldman Sachs Adjusts Price Target on Amgen to $350 From $359, Keeps Buy Rating	May. 03	MT
ANALYST RECOMMENDATIONS : Alphabet, Amgen, Starbucks, PayPal, Moderna...	May. 03
UBS Adjusts Amgen's Price Target to $284 From $314, Maintains Neutral Rating	Apr. 17	MT
TD Cowen Cuts Price Target on Amgen to $360 From $370, Buy Rating Kept	Apr. 15	MT
Goldman Sachs Adjusts Amgen Price Target to $359 From $361, Maintains Buy Rating	Apr. 15	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Amgen Inc.

Equities

AMGN

US0311621009

Analyst Reco.

Filters